Hantgo.com

Stay Informed Stay Ahead

Medicine

Registration opens for INTERPHEX 2025

Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place 1-3 April 2025, at the Javits Center in NYC. Here, attendees gain direct access to the tools they need to effectively accelerate their drug-to-market journey. 

Engage with leading experts during scientifically vetted education sessions, discover live demonstrations of machinery and equipment from a diverse offering of exhibitors, and forge valuable connections at INTERPHEX. This year’s program topics range from new manufacturing technologies, drug product acceleration, global access to medicines, dosage forms, CMC challenges, and solutions to supply chain challenges. 

Exhibit Hall Only and Single/Full Conference passes are now available for registration. Early bird pricing for exhibit hall will be available until 12th February 2025. 

INTERPHEX Conference in the Learning Lab 

A conference badge is required for attendees and exhibitors to access the Learning Lab – one day passes and full conference passes are available.  

The INTERPHEX Conference Program in the Learning Lab – an enclosed, private education space on the Show Floor – returns by popular demand. Sessions are vetted for scientific validity by an independent Scientific Programming Advisory Committee established in partnership with the American Association of Pharmaceutical Scientists (AAPS. Join an unmatched lineup of industry experts as they share experiences with real-world, problem-solving solutions.  

Two tracks will be offered across three stages – with dedicated themes for each stage. 

Track 1: Advanced Manufacturing – covers innovative manufacturing technologies that enhance efficiency and quality, accelerate drug products to market, and improve global access to medicines through cost-effective production, optimised distribution networks, and improved drug delivery mechanisms. 

Track 2: Ensuring Access to Innovative Medicines – focuses on patient-centric drug development, overcoming manufacturing challenges for novel therapies, and addressing supply issues for new therapeutics. Emphasis is placed on enhancing patient adherence, optimizing manufacturing processes, and integrating sustainability in drug production. 

“Building on the success of 2024, we’re thrilled to present an exceptional lineup of speakers who will address critical challenges in pharmaceutical innovation, biotechnology advancements, and supply chain optimisation,” said INTERPHEX event director Douglas Lugo. “This year’s program is designed to provide actionable insights into accelerating drug-to-market timelines, adopting cutting-edge manufacturing technologies, and enhancing global access to medicines. Our goal is to empower industry professionals with the knowledge and tools they need to drive success in an evolving landscape.” 

Show Floor Education Content 

All attendee and exhibitor badges have access to the Show Floor Content

INTERPHEX Show Floor Education Content is designed to elevate industry knowledge and collaboration for all badge types. The Contract Stage, centrally located in the Contract Zone, serves as a hub for CMO/CDMO companies, celebrating innovation and excellence in pharmaceutical and biopharmaceutical contract manufacturing. The Tech Theaters offer an engaging platform where exhibitors demonstrate groundbreaking technologies and advancements, providing attendees with an up-close look at the future of the industry. Meanwhile, the all-new Community Talks Theater delivers thought-provoking discussions, addressing key trends and challenges shaping the sector. Together, these stages create a dynamic environment for learning, networking, and discovering solutions to drive the industry forward. 

Show Floor Features 

The return of our popular show floor features encourages community building through a better-connected, centralized experience, and exhibit spaces and events. 

Designed to highlight the unique areas of the industry, the show floor will feature our Contract Zone Pavilion, the New Exhibitor Pavilion, and Special Events/Happy Hours to encourage networking and collaboration.   

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *

Medicine

Aramex Scoop Sustainability AwardGlobal logistics giant Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability from those that are directly involved in the design, development or distribution of pharmaceuticals – a sector in which Aramex has a significant footprint. Despite being up against fierce competition within their selected category, the judges ruled that Aramex’s unwavering commitment to sustainability, environmental stewardship, and mitigating climate risks were what tipped the scales on the night. Citing a 42% reduction based on scope 1 & 2 and a 25% reduction on scope 3, dependent on supplier commitment, Aramex has since 2006 implemented a multifaceted climate change mitigation strategy with the sole aim of minimising its carbon footprint and improving its impact on the environment. This strategy involves investment into renewable energy projects, commitment to minimising waste and promoting recycling across its network, enhancing energy efficiency across its operations, with initiatives such as ISO 14001 certification, LEED certification for its facilities along with further energy efficiency projects to drive down usage. Reduced water consumption, route optimisation projects to reduce fuel consumption and emissions, and a commitment to gradually transitioning its fleet to electric and low-emission vehicles have also been put in place. Aramex has also implemented its Future Vehicle Program which explores innovative solutions such as autonomous vehicles and drone deliveries to enhance efficiency and reduce environmental impact in the years to come. Ronan Kitchin who heads up the Life Science and Healthcare division at Aramex UK commented: “We are delighted to have been recognised by Distributing Pharmaceuticals at their recent award event for our work in driving sustainability initiatives throughout our distribution services – a commitment which we have made significant strides towards over the past two decades. “With a legacy of championing sustainability, our environmental and climate change mitigation strategy looks to deliver tangible and positive changes in reducing emissions across the entire business – whether that be in our efforts to minimise waste or reducing fuel consumption. Ensuring our footprint is kept at a minimum where possible is at the top of our agenda and we couldn’t be prouder that this has been recognised by an independent panel of respected industry experts within the pharmaceutical industry – a sector within which we have a long and proud history serving. “Ultimately, it’s about doing the right thing. The world is undergoing a rate of change which is incomparable to anything humankind has ever faced before and therefore all need to play their part if the collective goal of defeating the worsening climate crisis is to be achieved. A huge thanks must therefore go out to all team members across the Aramex network who have each played a part in helping the company make such incredible inroads in its own sustainability goals.”